aspalathin and Cardiomyopathies

aspalathin has been researched along with Cardiomyopathies* in 1 studies

Other Studies

1 other study(ies) available for aspalathin and Cardiomyopathies

Article	Year
Aspalathin Reverts Doxorubicin-Induced Cardiotoxicity through Increased Autophagy and Decreased Expression of p53/mTOR/p62 Signaling. Molecules (Basel, Switzerland), 2017, Sep-22, Volume: 22, Issue:10 Topics: Animals; Apoptosis; Autophagy; Cardiomyopathies; Cell Line; Cell Line, Tumor; Chalcones; Dexrazoxane; Doxorubicin; Humans; Oxidative Stress; Rats; Signal Transduction; Tumor Suppressor Protein p53	2017

Article

Year

Aspalathin Reverts Doxorubicin-Induced Cardiotoxicity through Increased Autophagy and Decreased Expression of p53/mTOR/p62 Signaling.

Molecules (Basel, Switzerland), 2017, Sep-22, Volume: 22, Issue:10

Topics: Animals; Apoptosis; Autophagy; Cardiomyopathies; Cell Line; Cell Line, Tumor; Chalcones; Dexrazoxane; Doxorubicin; Humans; Oxidative Stress; Rats; Signal Transduction; Tumor Suppressor Protein p53

2017